# Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.

> PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17064208-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17064208-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17064208-pramlintide-v1.json
- Content SHA-256: `2fa0a669bf8f112a8510026f6ff4e35faa8aaa334f1438b0586679bf8c8a4e09`

## Claims and source pins

### Headline

Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

### Summary

PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

### Paragraph 1

PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`](#source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8))

## Sources

<a id="source-pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8"></a>
- **Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. · retained source version 1:2026-01-28:current:fa251b343ad891312060e741d73844c29f7b0dc686f7f3b1e840747757874074** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17064208/) (`pubmed-observation-pmid-17064208-2026-01-28-fa251b343ad8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17064208-pramlintide-v1.json SHA-256: 2fa0a669bf8f112a8510026f6ff4e35faa8aaa334f1438b0586679bf8c8a4e09.